Ryan M Pedrigi1, Christian Bo Poulsen1, Vikram V Mehta1, Niels Ramsing Holm1, Nilesh Pareek1, Anouk L Post1, Ismail Dogu Kilic1, Winston A S Banya1, Gianni Dall'Ara1, Alessio Mattesini1, Martin M Bjørklund1, Niels P Andersen1, Anna K Grøndal1, Enrico Petretto1, Nicolas Foin1, Justin E Davies1, Carlo Di Mario1, Jacob Fog Bentzon1, Hans Erik Bøtker1, Erling Falk1, Rob Krams1, Ranil de Silva2. 1. From Department of Bioengineering, Imperial College London, United Kingdom (R.M.P., V.V.M., A.L.P., R.K.); Institute of Clinical Medicine, Aarhus University Hospital, Denmark (C.B.P., N.R.H., M.M.B., N.P.A., A.K.G., J.F.B., E.F.); Department of Cardiology, Aarhus University Hospital, Denmark (C.B.P., N.R.H., M.M.B., N.P.A., A.K.G., J.F.B., H.E.B., E.F.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom (I.D.K., W.A.S.B., G.D.'A., A.M., C.D.M., R.d.S.); Graduate Medical School, Duke-National University of Singapore, Singapore (E.P.); National Heart Centre, NHRIS, Singapore (N.F.); National Heart and Lung Institute, Imperial College London, United Kingdom (C.D.M., R.d.S.); and Institute of Cardiovascular Medicine and Science, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom (C.D.M., R.d.S.). 2. From Department of Bioengineering, Imperial College London, United Kingdom (R.M.P., V.V.M., A.L.P., R.K.); Institute of Clinical Medicine, Aarhus University Hospital, Denmark (C.B.P., N.R.H., M.M.B., N.P.A., A.K.G., J.F.B., E.F.); Department of Cardiology, Aarhus University Hospital, Denmark (C.B.P., N.R.H., M.M.B., N.P.A., A.K.G., J.F.B., H.E.B., E.F.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom (I.D.K., W.A.S.B., G.D.'A., A.M., C.D.M., R.d.S.); Graduate Medical School, Duke-National University of Singapore, Singapore (E.P.); National Heart Centre, NHRIS, Singapore (N.F.); National Heart and Lung Institute, Imperial College London, United Kingdom (C.D.M., R.d.S.); and Institute of Cardiovascular Medicine and Science, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom (C.D.M., R.d.S.). r.desilva@imperial.ac.uk.
Abstract
BACKGROUND: Although disturbed flow is thought to play a central role in the development of advanced coronary atherosclerotic plaques, no causal relationship has been established. We evaluated whether inducing disturbed flow would cause the development of advanced coronary plaques, including thin cap fibroatheroma. METHODS AND RESULTS: D374Y-PCSK9 hypercholesterolemic minipigs (n=5) were instrumented with an intracoronary shear-modifying stent (SMS). Frequency-domain optical coherence tomography was obtained at baseline, immediately poststent, 19 weeks, and 34 weeks, and used to compute shear stress metrics of disturbed flow. At 34 weeks, plaque type was assessed within serially collected histological sections and coregistered to the distribution of each shear metric. The SMS caused a flow-limiting stenosis, and blood flow exiting the SMS caused regions of increased shear stress on the outer curvature and large regions of low and multidirectional shear stress on the inner curvature of the vessel. As a result, plaque burden was ≈3-fold higher downstream of the SMS than both upstream of the SMS and in the control artery (P<0.001). Advanced plaques were also primarily observed downstream of the SMS, in locations initially exposed to both low (P<0.002) and multidirectional (P<0.002) shear stress. Thin cap fibroatheroma regions demonstrated significantly lower shear stress that persisted over the duration of the study in comparison with other plaque types (P<0.005). CONCLUSIONS: These data support a causal role for lowered and multidirectional shear stress in the initiation of advanced coronary atherosclerotic plaques. Persistently lowered shear stress appears to be the principal flow disturbance needed for the formation of thin cap fibroatheroma.
BACKGROUND: Although disturbed flow is thought to play a central role in the development of advanced coronary atherosclerotic plaques, no causal relationship has been established. We evaluated whether inducing disturbed flow would cause the development of advanced coronary plaques, including thin cap fibroatheroma. METHODS AND RESULTS: D374Y-PCSK9 hypercholesterolemic minipigs (n=5) were instrumented with an intracoronary shear-modifying stent (SMS). Frequency-domain optical coherence tomography was obtained at baseline, immediately poststent, 19 weeks, and 34 weeks, and used to compute shear stress metrics of disturbed flow. At 34 weeks, plaque type was assessed within serially collected histological sections and coregistered to the distribution of each shear metric. The SMS caused a flow-limiting stenosis, and blood flow exiting the SMS caused regions of increased shear stress on the outer curvature and large regions of low and multidirectional shear stress on the inner curvature of the vessel. As a result, plaque burden was ≈3-fold higher downstream of the SMS than both upstream of the SMS and in the control artery (P<0.001). Advanced plaques were also primarily observed downstream of the SMS, in locations initially exposed to both low (P<0.002) and multidirectional (P<0.002) shear stress. Thin cap fibroatheroma regions demonstrated significantly lower shear stress that persisted over the duration of the study in comparison with other plaque types (P<0.005). CONCLUSIONS: These data support a causal role for lowered and multidirectional shear stress in the initiation of advanced coronary atherosclerotic plaques. Persistently lowered shear stress appears to be the principal flow disturbance needed for the formation of thin cap fibroatheroma.
Authors: Lucas H Timmins; David S Molony; Parham Eshtehardi; Michael C McDaniel; John N Oshinski; Don P Giddens; Habib Samady Journal: J R Soc Interface Date: 2017-02 Impact factor: 4.118
Authors: Lucas H Timmins; David S Molony; Parham Eshtehardi; Emad Rasoul-Arzrumly; Adrian Lam; Olivia Y Hung; Michael C McDaniel; John N Oshinski; Don P Giddens; Habib Samady Journal: Int J Cardiovasc Imaging Date: 2016-11-14 Impact factor: 2.357
Authors: Natalia V Mushenkova; Volha I Summerhill; Yulia Yu Silaeva; Alexey V Deykin; Alexander N Orekhov Journal: Am J Transl Res Date: 2019-08-15 Impact factor: 4.060
Authors: Adam J Brown; Zhongzhao Teng; Paul C Evans; Jonathan H Gillard; Habib Samady; Martin R Bennett Journal: Nat Rev Cardiol Date: 2016-01-29 Impact factor: 32.419
Authors: Gábor Tamás Szabó; Áron Üveges; Balázs Tar; András Ágoston; Azzaya Dorj; Csaba Jenei; Rudolf Kolozsvári; Benjamin Csippa; Dániel Czuriga; Zsolt Kőszegi Journal: J Clin Med Date: 2021-04-28 Impact factor: 4.241
Authors: Yiannis S Chatzizisis; Konstantinos Toutouzas; Andreas A Giannopoulos; Maria Riga; Antonios P Antoniadis; Yusuke Fujinom; Dimitrios Mitsouras; Vassilis G Koutkias; Grigorios Cheimariotis; Charalampos Doulaverakis; Ioannis Tsampoulatidis; Ioanna Chouvarda; Ioannis Kompatsiaris; Sunao Nakamura; Frank J Rybicki; Nicos Maglaveras; Dimitris Tousoulis; George D Giannoglou Journal: Eur Heart J Cardiovasc Imaging Date: 2017-05-01 Impact factor: 6.875